Search research articles
Contact Us
Filters
Showing results (31-40 of 168) with videos related to
Page
of 17
Sort By:
Neurologia I Neurochirurgia Polska
|
March 3, 2025
Do Parkinson's Disease clinical subtypes really exist?
Marta Filidei, Luca Marsili, Carlo Colosimo
Journal of Neural Transmission (Vienna, Austria : 1996)
|
June 29, 2026
Neurodegenerative diseases and environmental risk factors: an overview of the available scientific evidence
Giuseppe Stipa, Carlo Colosimo, Nicola Vanacore
Internal and Emergency Medicine
|
May 22, 2012
Thrombolysis in hemiballism: is it a rational choice?
Agata Correnti, Danilo Toni, Carlo Colosimo
Biomedicines
|
January 21, 2022
Movement Disorders in Oncology: From Clinical Features to Biomarkers
Luca Marsili, Alberto Vogrig, Carlo Colosimo
Frontiers in Neurology
|
April 10, 2018
Diagnostic Criteria for Parkinson's Disease: From James Parkinson to the Concept of Prodromal Disease
Luca Marsili, Giovanni Rizzo, Carlo Colosimo
Neurotoxicity Research
|
February 24, 2012
Efficacy and safety of long-term botulinum toxin treatment in craniocervical dystonia: a systematic review
Carlo Colosimo, Dorina Tiple, Alfredo Berardelli
Journal of Neurology
|
November 17, 2010
Levodopa: back to the future
Mario Zappia, Carlo Colosimo, Werner Poewe
Expert Opinion on Pharmacotherapy
|
June 10, 2023
Emerging Symptomatic Treatment of Chronic Traumatic Encephalopathy (CTE): a narrative review
Carlo Rossi, Nicole Campese, Carlo Colosimo
Movement Disorders Clinical Practice
|
March 7, 2019
How Do I Examine Blepharospasm?
Carlo Colosimo, Matteo Bologna, Alfredo Berardelli
Frontiers in Integrative Neuroscience
|
March 1, 2012
Deep brain stimulation for movement disorders - a history of success and challenges to conquer
Lars Wojtecki, Carlo Colosimo, Romulo Fuentes
Page
of 17
Search research articles
Search
Showing results (31-40 of 168) with videos related to
Sort By:
Page
of 17
Neurologia I Neurochirurgia Polska
|
March 3, 2025
Do Parkinson's Disease clinical subtypes really exist?
Marta Filidei, Luca Marsili, Carlo Colosimo
Journal of Neural Transmission (Vienna, Austria : 1996)
|
June 29, 2026
Neurodegenerative diseases and environmental risk factors: an overview of the available scientific evidence
Giuseppe Stipa, Carlo Colosimo, Nicola Vanacore
Internal and Emergency Medicine
|
May 22, 2012
Thrombolysis in hemiballism: is it a rational choice?
Agata Correnti, Danilo Toni, Carlo Colosimo
Biomedicines
|
January 21, 2022
Movement Disorders in Oncology: From Clinical Features to Biomarkers
Luca Marsili, Alberto Vogrig, Carlo Colosimo
Frontiers in Neurology
|
April 10, 2018
Diagnostic Criteria for Parkinson's Disease: From James Parkinson to the Concept of Prodromal Disease
Luca Marsili, Giovanni Rizzo, Carlo Colosimo
Neurotoxicity Research
|
February 24, 2012
Efficacy and safety of long-term botulinum toxin treatment in craniocervical dystonia: a systematic review
Carlo Colosimo, Dorina Tiple, Alfredo Berardelli
Journal of Neurology
|
November 17, 2010
Levodopa: back to the future
Mario Zappia, Carlo Colosimo, Werner Poewe
Expert Opinion on Pharmacotherapy
|
June 10, 2023
Emerging Symptomatic Treatment of Chronic Traumatic Encephalopathy (CTE): a narrative review
Carlo Rossi, Nicole Campese, Carlo Colosimo
Movement Disorders Clinical Practice
|
March 7, 2019
How Do I Examine Blepharospasm?
Carlo Colosimo, Matteo Bologna, Alfredo Berardelli
Frontiers in Integrative Neuroscience
|
March 1, 2012
Deep brain stimulation for movement disorders - a history of success and challenges to conquer
Lars Wojtecki, Carlo Colosimo, Romulo Fuentes
Page
of 17